A new FDA-approved drug for Alzheimer’s signals a breakthrough in innovation for patients and caregivers, but has raised doubts from some over the price tag and approval process. Confused about what all of this means for you? This episode breaks it down.
Dr. Bob walks listeners through the accelerated approval process while Terry looks at the role this plays in future medical innovation. Sue Peschin, President and CEO of the Alliance for Aging Research, explains how the price tag fits into the ongoing debate over drug pricing policies. And we hear from Allison Wilson, who gives a caregiver’s perspective as she reflects on her mother’s diagnosis of early-onset Alzheimer’s.
Terry Wilcox, Executive Director, Patients Rising
Dr. Robert Goldberg, “Dr. Bob,” Co-Founder and Vice President of the Center for Medicine in the Public Interest
Sue Peschin, President and CEO, Alliance for Aging Research
Allison Wilson, Caregiver
Becky Brandt, Patient Correspondent
Alliance for Aging Research + Milliman Report on Assessing Value of Alzheimer’s Treatments
The successful patient is one who can get what they need when they need it. We all know insurance slows us down, so why not take matters into your own hands? Our Navigator is an online tool that allows you to search a massive network of health-related resources using your zip code so you get local results. Get proactive and become a more successful patient right now at PatientsRisingConcierge.org
Have a question or comment about the show, or want to suggest a show topic or share your story as a patient correspondent?
Drop us a line: email@example.com
The views and opinions expressed herein are those of the guest(s)/ author(s) and do not reflect the official policy or position of Patients Rising.
Ahead of Rare Disease Day, Congresswoman Cathy McMorris Rodgers (WA-05) joins the podcast to discuss new legislation that would ban the use of a discriminatory health care metric, quality adjusted life year, or QALY. Learn ho...
Stephen Kay took a job 10 hours away from his wife. Why? Because he needed insurance that would cover the costs of her multiple sclerosis care. While she had Medicare before turning 65, she was unable to purchase a supplement...
Is the cost of your health care going up? Have you struggled to access the care your doctor recommends? A group of physicians and health care experts are working to address these growing problems and make care patient-centere...